Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.120
-0.090 (-2.14%)
Mar 3, 2026, 4:00 PM EST - Market closed
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $502.65 million as of March 3, 2026. Its market cap has increased by 58.87% in one year.
Market Cap
502.65M
Enterprise Value
414.97M
1-Year Change
58.87%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $502.65M, an increase of 27.83%. That is a compound annual growth rate of 3.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 513.63M | -34.83% |
| Dec 31, 2025 | 788.14M | 142.81% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 779.27M |
| Ironwood Pharmaceuticals | 536.46M |
| Kamada | 500.76M |
| Eton Pharmaceuticals | 463.41M |
| SIGA Technologies | 454.73M |
| Canopy Growth | 426.72M |
| Emergent BioSolutions | 423.05M |
| Organogenesis Holdings | 398.85M |